192. コケイン症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 4 / 薬物数 : 5 - (DrugBank : 3) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 49
薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Prodarsan
DNage B.V.
2010 Phase 1/Phase 2 NCT01142154 United States
Quercetin
The First Medical Center of PLA General Hospital
2019 Phase 0 ChiCTR1900026719 China
Sirolimus
Premier Specialists, Australia
2016 Phase 2 NCT03016715 Australia
Stanford University
2016 Phase 2 NCT02960997 United States
Vehicle
Premier Specialists, Australia
2016 Phase 2 NCT03016715 Australia
Stanford University
2016 Phase 2 NCT02960997 United States
Vitamin C
The First Medical Center of PLA General Hospital
2019 Phase 0 ChiCTR1900026719 China
DNage B.V.
2010 Phase 1/Phase 2 NCT01142154 United States
Quercetin
The First Medical Center of PLA General Hospital
2019 Phase 0 ChiCTR1900026719 China
Sirolimus
Premier Specialists, Australia
2016 Phase 2 NCT03016715 Australia
Stanford University
2016 Phase 2 NCT02960997 United States
Vehicle
Premier Specialists, Australia
2016 Phase 2 NCT03016715 Australia
Stanford University
2016 Phase 2 NCT02960997 United States
Vitamin C
The First Medical Center of PLA General Hospital
2019 Phase 0 ChiCTR1900026719 China